| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |